EDVANYSEBeveragesFiscal year ends December 31
Endovia Health Sciences, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026
$0.14−0.01 (-7.53%)
Close on Oct 19, 2026
- Market cap
- $413.76K
- P/E (TTM)
- –
- Dividend yield
- –
Endovia Health Sciences, Inc. revenue by segment
By business segment
By product or service
| Revenue | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q4 21 | TTM Q4 20 | TTM Q4 19 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| E Commerce [Member] | $59.01K | $269.75K | $341.39K | $364.76K | $646.15K | $6.86M | $1.90M | – | 100.0% | -90.9% |
| Splash Beverage Group [Member] | – | $777.77K | $1.29M | $2.32M | $155.12K | $4.46M | $404.13K | $20.39K | – | – |
By region
From the segment and revenue-disaggregation notes of Endovia Health Sciences's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.